ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyLiestalCuratis AG
Curatis AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

Curatis AG is a specialty pharmaceutical company that acquires, develops and commercialises medicines for rare diseases and specialty care. It distributes its own products and those of partner companies and develops drug candidates for these medical indications.

AI-generated
Offering

Products & services

Industry:Pharmaceutical company
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Curatis AG

Pharmaceutical wholesaler
✓ Offered5
Distribution and commercialization of specialty and orphan medicines
Acquisition, licensing, distribution and marketing of medicines for rare and specialty diseases in Switzerland; exclusive distribution rights for numerous products and international partner medicines.
Development of orphan and specialty-care medicines
Development of new specialty and orphan drugs with existing safety and efficacy data; pipeline projects in preclinical and clinical development for rare diseases and conditions with specific care needs.
Commercial partnerships for Switzerland
Tailored partner packages for the commercialization of pharmaceutical products in Switzerland, including market access, registration, pricing, reimbursement, marketing, sales, early-access programmes and pharmacovigilance.
Partnerships for the development of new medicines
Co-development and licensing models for late-stage clinical development projects with biotech, pharma and contract research and manufacturing organizations.
Medicines portfolio
Portfolio of medicines marketed and distributed in Switzerland for pain, oncology, urology, endocrinology, ophthalmology, infectiology, neurology and other therapeutic specialties.
Trust & reputation

ranQ Trust Score of Curatis AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of November 2026

Without public customer reviews the score stays capped.

Curatis AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Curatis AG scores 92.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Curatis AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Curatis AG scores 64.8 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.82.94%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.46.74%
Qualifications+0.00

Curatis AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

June 30, 2026Media
Curatis erhöht Umsatzwachstumsprognose für 2026
cash.ch
March 24, 2026Media
Curatis steigert Umsatz deutlich und will 2026 schwarze Zahlen schreiben
cash.ch
April 26, 2024Media
Kinarus heisst ab sofort Curatis
fuw.ch

Knowledge

No knowledge articles yet

Once Curatis AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Curatis AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Curatis AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Curatis AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Weierweg 7
4410 Liestal

At a glance

Legal form
Corporation
UID
CHE-108.721.090
Founded
1993 · 33 years
Last commercial register change
June 3, 2026
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SP
    Schaer Pharma Service GmbH
    Itingen
    AP
    Acino Pharma AG
    Liesberg
    MP
    Merz Pharma (Schweiz) AG
    Allschwil
    BP
    Basilea Pharmaceutica International AG, Allschwil
    Allschwil
    BP
    Basilea Pharmaceutica AG, Allschwil
    Allschwil
    PP
    Perseo pharma AG
    Muttenz
    PT
    Palto Therapeutics AG
    Allschwil
    RA
    Renaldee AG
    Augst Bl